New study tests simple blood thinner to protect new moms from deadly clots

NCT ID NCT07140211

Recruiting now Prevention Sponsor: Marc Blondon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study is testing whether giving new mothers a low-dose blood thinner for just 7-10 days after delivery can prevent blood clots in the legs or lungs. About 9,200 women with certain risk factors (like emergency C-section, obesity, or pre-eclampsia) will either receive the drug or no treatment. The goal is to see if this short-term approach reduces clot risk without causing serious bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

puerperal disorder venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTPARTUM VENOUS THROMBOEMBOLISM (VTE)

Contacts and locations

Locations

Centre Hospitalier Universitaire Vaudois
RECRUITING

Lausanne, Switzerland
Ente Ospedaliero Cantonale
RECRUITING

Lugano, Switzerland
Geneva University Hospitals
RECRUITING

Geneva, Switzerland
Hôpital du Valais
RECRUITING

Sion, Switzerland
Kantonsspital Baden
RECRUITING

Baden, Switzerland
Lindenhofspital
RECRUITING

Bern, Switzerland
Réseau Hospitalier Neuchâtelois
RECRUITING

Neuchâtel, Switzerland
Universitätsspital Basel
RECRUITING

Basel, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.